← Back to Search

Health IT with AI & Interpreters for Patients with Language Barriers and Complex Needs

N/A

Waitlist Available

Led By Brian Pickering, MB, B.Ch

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial tests if AI & interpreters can help people with complex care needs & language barriers get help quicker.

Who is the study for?

This trial is for adults who speak limited English, need an interpreter, and have complex medical needs like ICU stays or palliative care. Participants must also consent to be part of the research.Check my eligibility

What is being tested?

The study tests if AI can help identify patients with language barriers and complex care needs, and whether it improves the use of interpreters in healthcare settings by notifying clinicians.See study design

What are the potential side effects?

Since this trial involves health IT rather than medication, traditional side effects are not applicable. However, there may be privacy concerns or miscommunications due to technology errors.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of interpreters

Secondary outcome measures

Change in time to interpreter use

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This is the group in units who are identified via AI model and in which interpreter services are actively reaching out to clinicians

Group II: ControlActive Control1 Intervention

This is the control group who receive standard of care

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,206 Previous Clinical Trials

3,758,683 Total Patients Enrolled

Brian Pickering, MB, B.ChPrincipal InvestigatorMayo Clinic

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05860777 — N/A

Limited English Proficiency Research Study Groups: Control, Intervention

Limited English Proficiency Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05860777 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05860777 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical research actively seeking participants?

"Clinicaltrials.gov reports that this experiment is not actively recruiting patients at the moment, despite being posted on May 1st of 2023 and updated 8 days later. While this particular study may be inactive, there are 25 other trials still seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Harnessing Health IT to Promote Equitable Care for Patients With Limited English Proficiency and Complex Care Needs

Brian W. Pickering, M.B., B.Ch. 2023. "Harnessing Health IT to Promote Equitable Care for Patients With Limited English Proficiency and Complex Care Needs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05860777.